Cancer drug also 'slows progress' of fatal lung disease
A major international study has found that a drug previously used as a cancer treatment can significantly slow the progression of a fatal lung disease.
Get unlimited access
As a subscriber you will benefit from:
- Full online and mobile access to news and opinion stories
- Customised email alerts straight to your inbox (30+ alerts available)
- 4,500 practice articles in our archive
- Over £500 worth of CPD learning units